HEPATITIS-C VIRUS-ANTIBODY IN ALCOHOLIC PATIENTS - ASSOCIATION WITH THE PRESENCE OF PORTAL AND OR LOBULAR HEPATITIS/

Citation
As. Rosman et al., HEPATITIS-C VIRUS-ANTIBODY IN ALCOHOLIC PATIENTS - ASSOCIATION WITH THE PRESENCE OF PORTAL AND OR LOBULAR HEPATITIS/, Archives of internal medicine, 153(8), 1993, pp. 965-969
Citations number
23
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00039926
Volume
153
Issue
8
Year of publication
1993
Pages
965 - 969
Database
ISI
SICI code
0003-9926(1993)153:8<965:HVIAP->2.0.ZU;2-N
Abstract
Objective: To evaluate the relationship between hepatitis C viral infe ction and alcoholic liver disease. Design: Case-comparison study. Sett ing: Bronx (NY) Veterans Affairs Medical Center. Participants: Forty-s even consecutive alcoholic patients undergoing diagnostic liver biopsy . Main Outcome Measures: Serum was obtained at the time of liver biops y and assayed for antibodies to hepatitis C virus using enzyme-linked immunosorbent assay, recombinant immunoblot assay, and hepatitis C vir us neutralization methods. Results: Antibody to hepatitis C virus, as confirmed by the recombinant immunoblot assay, was strongly associated with the presence of portal and/or lobular inflammation (91% seroposi tivity) but was only present in 16% of patients without this histologi c finding (P<.001). In patients without portal or lobular hepatitis, r ecombinant immunoblot assay seropositivity was seen in 27% of patients with cirrhosis and 20% of patients with alcoholic hepatitis and was a bsent in patients with steatosis and/or perivenular fibrosis. In the s ubgroup of alcoholic patients who were without known risk factors for hepatitis C virus infection (ie, no history of intravenous drug use or blood transfusions), antibody to hepatitis C virus was present in 78% of subjects with portal and/or lobular hepatitis but was absent in th ose with other types of alcoholic liver disease. Finally, anti-hepatit is C virus-seropositive patients had a significantly greater mean necr oinflammatory score as compared with anti-hepatitis C virus-seronegati ve alcoholic patients (2.1 vs 1.2; P<.001). In contrast, there was no significant difference in the mean fibrosis score between the two grou ps. Conclusions: The presence of portal and/or lobular inflammation is strongly associated with antibodies to hepatitis C virus in alcoholic patients, even in the absence of known risk factors. This association indicates that hepatitis C virus is responsible, at least in part, fo r the portal and/or lobular hepatitis associated with alcoholic liver disease.